Government to fund diabetes candidate trials in Hungary
This article was originally published in Scrip
Executive Summary
The Hungarian government has approved Ft1 billion ($5 million) in funding for clinical trials requested by N-Gene Research and Development (N-Gene Kutatasi es Fejlesztesi), a wholly owned local subsidiary of the US company N-Gene Research Laboratories (N-Gene), and Mecsek Pharma, an R&D spin-off of the Pecs university.